Astellas Pharma Global Development, Inc.

This study tested whether adding a new drug called gilteritinib to standard azacitidine treatment helps adults with a specific type of acute myeloid leukemia (AML) live longer. It focused on older adults or those with other health problems who could not tolerate strong chemothera…

This completed Phase 2 trial tested whether regular injections of an experimental drug called Zimura into the eye could safely slow the progression of vision loss in people with a rare genetic eye disease called Stargardt's. The study involved 121 participants who received either…

This large, completed Phase 3 trial tested whether adding the drug enzalutamide to standard hormone therapy (ADT) was better than hormone therapy alone for men whose prostate cancer had already spread. The main goal was to see if the combination could delay the cancer from gettin…

This study tested whether a new antibody drug called ASKP1240 could help prevent organ rejection after kidney transplantation. Researchers compared the new treatment to standard anti-rejection medications in 149 patients who received new kidneys. The goal was to see if the new ap…

This study tested a new drug called ASKP1240 in people with moderate to severe plaque psoriasis. The main goals were to check the drug's safety, how it moves through the body, and if it could improve skin symptoms. About 60 participants received either the drug or a placebo over …

This study tested whether a new targeted pill called gilteritinib (ASP2215) worked better than standard salvage chemotherapy for adults with a specific genetic type of acute myeloid leukemia (AML) that had come back or did not respond to first treatment. The main goals were to se…

This study tested whether a new drug called enfortumab vedotin helped people with advanced bladder cancer live longer than standard chemotherapy. It involved 608 adults whose cancer had spread or returned after previous treatments with immunotherapy and platinum-based chemotherap…

This study followed patients who had already completed a previous trial to check the long-term safety of avacincaptad pegol, an eye injection for geographic atrophy. Geographic atrophy is an advanced form of age-related macular degeneration that causes permanent vision loss. The …

This study tested a new fluorescent dye, ASP5354, to help surgeons see the ureter (the tube that carries urine) more clearly during abdominal and pelvic surgeries. The goal was to prevent rare but serious accidental injuries to this hard-to-see structure. During surgery, particip…

This study tested a new fluorescent dye, ASP5354, to help surgeons see the ureter (the tube that carries urine) more clearly during abdominal and pelvic surgeries. The goal was to prevent accidental damage to this delicate structure, which can be a rare but serious complication. …

This study tested whether a daily pill called fezolinetant could safely reduce the number and severity of hot flashes in Chinese women going through menopause. For 12 weeks, 150 women were randomly assigned to take either the real medicine or a placebo pill that looked the same b…

This study tested whether a new drug called ASP8062 could safely reduce pain and improve daily function for people with fibromyalgia. For 8 weeks, 183 participants received either the drug or a placebo pill, and researchers tracked their pain levels, side effects, and quality of …